Alphabet’s Verily launches consumer health app Verily Me

Published 17/10/2025, 15:36
© Reuters.

Investing.com -- Alphabet’s health technology company Verily has launched a new consumer health app called Verily Me, which was featured at HLTH USA 2025.

The free app provides users with personalized health recommendations from licensed clinicians based on medical records across multiple providers and health systems.

Verily Me includes several key features designed to help users manage their health. Users can receive tailored health recommendations from licensed clinicians who review their medical records. The app also allows patients to access their health history to inform discussions with healthcare providers.

A notable feature is Violet, an AI companion that answers questions about users’ health records in a secure environment. Users can ask specific questions like when they received their last flu vaccination or the name of a surgeon who performed a previous procedure.

Additional features include the ability to track meals by taking photos to receive real-time nutrition feedback, and the option to participate in Verily’s Lifelong Health Study, a real-world research registry.

"We created Verily Me to meet the consumer need for a simpler, more personalized healthcare solution," said Vindell Washington, Chief Clinical Officer at Verily. "Verily Me identifies care gaps and provides more personalized treatment recommendations, an important step towards our commitment to equipping individuals with the tools they need to better manage their health."

A recent Verily-sponsored survey conducted by The Harris Poll found that 75% of Americans would like an app that provides personalized health recommendations from healthcare providers and helps them better understand their health over time.

The app will also be used by members of Verily’s Lightpath personalized care program, which is subsidized by employers, payers, and pharmacy benefit managers. Lightpath currently focuses on cardiometabolic care management programs for people with conditions such as Type 1 and Type 2 diabetes, pre-diabetes, and obesity.

Verily has been providing virtual care solutions since 2018. The new app was built using Verily’s precision health platform, Pre, which transforms complex datasets for use across AI-enabled healthcare.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.